FDA Approves First Immune Globulin for Subcutaneous Use: "FDA today announced the approval of the first immune globulin product for subcutaneous injection for the prevention of serious infections in patients with Primary Immune Deficiency Diseases (PIDD)"
No comments:
Post a Comment